Rani Therapeutics Holdings, Inc. (RANI)
SEC filings, insider trading & institutional ownership from EDGAR.
Institutions
18
$6.66B held
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G · latest quarter
| Holder | Filed | Value |
|---|---|---|
| Vanguard Capital Management | Aug 13, 2026 | $3.47B |
| GEODE CAPITAL MANAGEMENT, LLC | Aug 12, 2026 | $677.58M |
| CITADEL ADVISORS LLC | Aug 14, 2026 | $500.19M |
| JANE STREET GROUP, LLC | Aug 14, 2026 | $378.22M |
| RENAISSANCE TECHNOLOGIES LLC | Aug 13, 2026 | $327.53M |
RANI's filings are public. The insight is one click away.
Scrutar's AI reads every RANI filing and surfaces what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Red Flag Detection20+ forensic checks per filingRisk RadarYear-over-year changes in risk factorsFiling DNADisclosure quality scored across six dimensionsSupply Chain GraphCustomers, suppliers & competitors mapped
Analyze RANI filingsNo credit cardAI reports included on the free plan
Never miss a RANI filing.
Get an email when RANI files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Aug 30, 2026Source: SEC EDGAR.